Huh JW, Jo M, Yoo J, Kim MS, Choi KH, Park HJ, Jue MS. Eccrine Squamous Syringometaplasia Associated with Pelubiprofen Therapy.
Ann Dermatol 2017;
29:334-336. [PMID:
28566912 PMCID:
PMC5438942 DOI:
10.5021/ad.2017.29.3.334]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2016] [Revised: 08/26/2016] [Accepted: 08/31/2016] [Indexed: 11/08/2022] Open
Abstract
Eccrine squamous syringometaplasia (ESS) is a histologically distinctive skin eruption occurring predominantly in acral or intertriginous areas presenting as erythematous macules, papules or patches. The etiology of ESS remains unclear, but it is usually reported in patients receiving chemotherapy for various malignant neoplasms. To date, only two cases of ESS associated with non-steroidal anti-inflammatory drugs (NSAIDs), which has distinctive clinical features and pathogenesis, have been reported in the literature. Herein, we report a rare and interesting case of ESS associated with pelubiprofen, a recently developed NSAID, which appeared after pelubiprofen therapy and resolved spontaneously after discontinuing the medication.
Collapse